Physician profile
Heather L Gawron
NPI 1194826271
$24,031.97
in general payments reported to CMS, 2019-2025
53 companies · $5,625 in 2025
The $5,625 reported for 2025 was more than what 98% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,526 · 2022: $5,596 · 2023: $3,830 · 2024: $6,455 · 2025: $5,625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $2,896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,013.83 |
| Travel and Lodging | $2,896.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,242.95 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Corevalve Evolut R |
| Abbott Laboratories | $2,569.06 | 2021-2025 | Aveir, Cardiomems, Ensite |
| Atricure, INC. | $1,710.63 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $1,482.49 | 2021-2025 | Wainua, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $1,416.96 | 2021-2025 | |
| Boston Scientific Corporation | $1,320.75 | 2021-2025 | Watchman Flx, Watchman, Watchman Access System |
| Amgen INC. | $1,219.98 | 2021-2025 | Repatha, Repatha, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,172.92 | 2021-2025 | Jardiance, Stiolto Respimat |
| Novo Nordisk INC | $1,106.04 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $883.48 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $789.46 | 2023-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $518.25 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $516.51 | 2022-2025 | Verquvo, Capvaxive, Belsomra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $503.18 | 2021-2024 | Lifevest |
| Pfizer INC. | $469.64 | 2021-2025 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $340.20 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Janssen Pharmaceuticals, INC | $329.94 | 2021-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $255.54 | 2021-2025 | |
| Impulse Dynamics (USA) INC. | $253.48 | 2023 | Optimizer |
| Biosense Webster, INC. | $247.13 | 2022-2023 | Carto 3 |
| Penumbra, INC. | $144.30 | 2025 | Indigo System |
| Convatec INC. | $143.00 | 2023 | |
| Esperion Therapeutics, INC. | $140.90 | 2021-2024 | Nexletol |
| Exact Sciences Corporation | $111.03 | 2024-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $109.96 | 2024-2025 | Gemtesa |
| Abiomed | $104.79 | 2023 | Impella |
| Abbvie INC. | $93.74 | 2021-2024 | |
| Alnylam Pharmaceuticals INC. | $86.05 | 2025 | Onpattro |
| Otsuka America Pharmaceutical, INC. | $62.79 | 2022-2023 | Rexulti |
| Kestra Medical Technology Services, INC. | $61.59 | 2023-2025 | Assure Wcd |
| Amarin Pharma, INC. | $43.40 | 2022 | |
| Heartflow, INC. | $43.04 | 2022 | |
| Agepha Pharma Fz LLC | $40.75 | 2024 | Lodoco |
| G Medical Diagnostic Services, INC. | $40.28 | 2022-2024 | Cardiac Monitoring Suite |
| Regeneron Healthcare Solutions, INC. | $38.44 | 2024 | Evkeeza |
| Irhythm Technologies, INC. | $38.15 | 2024 | Zio Monitor, Zio Xt Patch |
| Philips North America LLC | $36.01 | 2024 | (5091) Amb Mon & Diag Und |
| Biotronik INC. | $35.17 | 2023 | Biomonitor |
| Glaxosmithkline, LLC. | $29.59 | 2023-2024 | Arexvy |
| Cvrx, INC. | $29.14 | 2024 | Barostim Neo System |
| Takeda Pharmaceuticals U.S.A., INC. | $25.32 | 2022 | |
| Smith+Nephew, INC. | $24.07 | 2024 | Or3o Dual Mobility, Real Intelligence |
| Arbor Pharmaceuticals, INC. | $23.15 | 2021 | |
| Nevro Corp. | $22.99 | 2024 | Senza |
| Baxter Healthcare | $22.86 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Lundbeck LLC | $21.92 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $20.11 | 2021 | |
| Bardy Diagnostics, INC. | $20.00 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $18.94 | 2024 | Arcalyst |
| Ibsa Pharma INC. | $14.78 | 2025 | Licart, Flector, Tirosint |
| Halozyme INC | $13.46 | 2023 | |
| Jazz Pharmaceuticals INC. | $12.13 | 2022 | |
| Dexcom, INC. | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Gawron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.